$MACA News
Last published 2y ago
- 2y agoMACASLXNPESG Releases Report on Silexion Therapeutics: Pioneering RNAi Technology in the Fight Against KRAS-Driven CancersBusiness WireReport covers Silexion Therapeutics (NASDAQ:SLXN), a disruptive player in the precision oncology space, developing innovative RNAi therapies targeting KRAS-driven cancers, highlighting the company's impressive clinical
- 2y agoMACASLXNSilexion Therapeutics Ltd. and Moringa Acquisition Corp Announce Closing of their Business CombinationGlobeNewswireMODI'IN, Israel and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- Silexion Therapeutics Ltd. ("Silexion"), a clinical-stage, oncology-focused biotechnology company and Moringa Acquisition Corp (NASDAQ:MACA)
- 2y agoMACAMACAUMACAWSilexion, a Clinical-Stage, Oncology-Focused Biotechnology Company, to Become Publicly Traded Via Business Combination with Moringa Acquisition CorpGlobeNewswireSilexion's first generation product, Loder™, successfully tested in a multinational Phase 2a clinical trial in patients with non-resectable pancreatic cancer which harbors
- 3y agoMACAMACAUMACAWMORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSIONGlobeNewswireNew York, NY, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa" or the "Company") announced today that, in connection with its previously announced extraordinary general meeting in
- 3y agoMACAMACAUMACAWMORINGA ACQUISITION CORP ANNOUNCES ADJOURNMENT OF EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS TO FEBRUARY 9, 2023GlobeNewswireNew York, NY, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa" or the "Company") announced today that, the extraordinary general meeting in lieu of the 2022 annual general meeting of
- 3y agoMACAMACAUMACAWMORINGA ACQUISITION CORP ANNOUNCES CONTRIBUTION TO TRUST ACCOUNT IN CONNECTION WITH PROPOSED EXTENSIONGlobeNewswireNew York, NY, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NASDAQ:MACA) ("Moringa" or the "Company") announced today that, in connection with its previously announced extraordinary general meeting in
- 4y agoMACAMACAUMACAWHolisto, a Technology-Based Online Travel Booking Platform, to Become Publicly Traded Via Business Combination with Moringa Acquisition CorpGlobeNewswireHolisto's advanced AI technology addresses the fragmented and complex travel booking market, providing consumers with a more affordable and personalized offering Since commercial product launch in Q2 2020, Holisto's online booking platform has gained s
- 4y agoMACAMACAUMACAWMoringa Acquisition Corp Files its Annual Report for the 2021 YearGlobeNewswireNEW YORK, NY, April 05, 2022 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NasdaqCM: MACA, MACAU and MACAW) (the "Company") announced that it filed its annual report on Form 10-K for the year ended December 31, 2021 with the Securities and Exchange Com
- 4y agoDRTSMACAVBLTAlpha Tau Medical Ltd. Appoints Ruth Alon to its Board of DirectorsPR NewswireJERUSALEM, March 21, 2022 /PRNewswire/ -- Alpha Tau Medical Ltd. (NASDAQ:DRTS), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced the appointment of Ms. Ruth (Ruti) Alon to its Board of Directors, effective im
- 5y agoMACAUMACAWMACAMoringa Acquisition Corp Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing April 7, 2021GlobeNewswireNEW YORK, NY, April 05, 2021 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (NasdaqCM: MACAU) (the “Company”) announced today that, commencing April 7, 2021, holders of the units sold in the Company’s...
- 5y agoMACAMoringa Acquisition Corp Announces Pricing of $100 Million Initial Public OfferingGlobeNewswireNEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Moringa Acquisition Corp (the “Company”) announced today that it priced its initial public offering of 10,000,000 units at $10.00 per unit. The units are...